Share
4,958 Posts.
lightbulb Created with Sketch. 5006
clock Created with Sketch.
16/08/21
15:43
Share
Originally posted by Dhm:
↑
It continues to bother me, especially given the continuing positive outlook, that the Board and management haven’t bought any shares around these levels. The prospects of ResApp seemingly have never looked better however the SP has never looked worse. Personally I can’t reconcile this anomaly especially whilst I maintain a bullish viewpoint. Surely we must be close to signing one or more Telehealth providers especially as TK has publicly stated ‘we are in advanced discussions with multiple parties’ or words to that effect. We are seemingly confident about identifying the COVID cough as we have extended US trials and instigated an Indian study. The mere fact that others are conducting similar studies with inferior or no identifiable cough recordings gives me greater confidence that we are on the money. So where is management and the Board of Directors? This is the time to dispel doubt and lead from the front. Dispel the market’s weakness and reticence with a lead from the front share play.
Expand
Agreed, unfortunately. Retail shareholders: “It’s being accumulated and capped, this is such amazing value, the SP will pop in just a few weeks. Massive revenue potential. Big deal with Medgate. Always about Europe.” Management and T20 after 12 month downtrend: still not buying.